Objective: Microalbuminuria is a renal marker of general vascular endothelial damage and early atherosclerosis with adverse prognostic implications. Microalbuminuria is associated with diabetes, insulin resistance, central adiposity and hypertension. We evaluated the degree of the association of components of the metabolic syndrome with microalbuminuria in a subsample of a nondiabetic study population. Design: Men and women aged 25-74 living in the city of Augsburg, Germany, were interviewed and examined in a standardised manner at a population-based survey conducted in 1994/95. Persons with a history of diabetes or HbA1c level у7% were excluded. Outcome: Albumin and creatinine were determined quantitatively in a spot urine and defined as microalbuminuria via an albumin/creatinine ratio between 30 and 299 mg/g. Results: Among 920 men and 879 women, the agestandardised prevalence of microalbuminuria was 8.0%
Introduction
While microalbuminuria is an established marker of declining renal function in diabetes mellitus, it has been proposed that in non-diabetic individuals, microalbuminuria may be the renal expression of general vascular endothelial damage, specifically, increased vascular permeability, and thus an early indicator of atherosclerosis. 1 Furthermore, it is well established that microalbuminuria is related to hypertension and its severity. research has shown that microalbuminuria is associated with insulin resistance 3 and central adiposity 4 which in turn has been linked to hypertension and cardiovascular disease in the context of the insulin resistance or metabolic syndrome. 5 Our purpose was to evaluate to what degree components of the metabolic syndrome such as obesity, central adiposity, body fat and hypertension are associated with microalbuminuria and whether they modify the relation of hypertension and early renal damage. In contrast to most previous studies, our study included measures of anthropometry and body composition in a large, population-based survey of free-living persons spanning a wide age range living in an urban environment.
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Materials and methods
Study design
The 1994/95 survey was conducted in the framework of the multinational World Health Organization (WHO) MONICA (Monitoring Trends and Determinants in Cardiovascular Diseases) project. 6 The MONICA Augsburg study region comprises the city of Augsburg and two adjacent counties. An independent sample of 6640 individuals was drawn from the Augsburg population age 25-74 years in 1994 by applying a two-stage cluster sample that has been described in detail. 7 Data were gathered from October 1994 to June 1995 through interview and physical examination including a venous blood sample and spot urine. For logistical reasons a spot urine sample was only collected from participants at the Augsburg city field centres. Of 3020 eligible persons in Augsburg city, 71% (n = 2136) participated in the study.
At the examination, systolic and diastolic blood pressure were measured in sitting subjects with the Hawksley random zero sphygmomanometer three times under standardised conditions in accordance with the MONICA manual. 8, 9 All blood pressure values are based on the first and fifth phase of the Korotkoff sounds and on the calculation of the mean of the second and third blood pressure measurements. Non-fasting blood samples were drawn under standardised conditions. 10 Glycosylated hemoglobin (HbA1c) was measured quantitatively with an immunologic test kit (Tina-quant  Hämoglo-bin A1c Boehringer Mannheim, Mannheim, Germany). Serum total cholesterol and high-density lipoprotein (HDL)-cholesterol analyses were carried out with an autoanalyzer by a clinical laboratory (Zentralklinikum Augsburg, Germany). An enzymatic method (CHOD-PAP; Boehringer Mannheim) was applied; HDL-cholesterol was precipitated with phosphotungstate/Mg 2+ . Internal and external quality control was performed.
A spot urine was collected, cooled and transported to the laboratory at the end of each day and analysed the following work day. Albumin was assessed quantitatively with an immunoturbidimetric test (Tina-quant  Albumin in urine, Boehringer Mannheim) and creatinine was measured quantitatively with an enzymatic colorimetric test (Hitachi 717, Boehringer Mannheim). The albuminto-creatinine ratio (mg/g) was used since the accuracy of the ratio in comparison to a 24-h urine sample has been demonstrated. 11 The sensitivity limits for albumin were 3-3000 mg/l.
For determination of anthropometric measures, participants were asked to remove shoes and heavy clothing. Body weight was measured to the nearest 0.1 kg on a scale (SECA 709) with attached height measure (SECA 207 
Statistical methods
Measured variables were categorised in the following manner. An albumin-to-creatinine ratio between 30 and 299 mg/g was defined as microalbuminuria and a level у300 mg/g as proteinuria in accordance with previous publications. 13, 14 Obesity was defined by a BMI у30 kg/m 2 . 15 Waist circumference and waist-to-hip ratio more than or equal to the 80th gender-specific percentiles of the analysis population were used to define elevated waist circumference and central adiposity. The 80th percentiles corresponded to a waist circumference у103 cm in men (у92 cm in women) and a waistto-hip ratio у0.972 in men (у0.852 in women). Diabetes was ascertained either by a self-reported physician diagnosis or by a measured HbA1c value у7%.
16 Subjects being aware of their hypertension and taking antihypertensive medication or those having blood pressure values у160 mm Hg systolic and/or 95 mm Hg diastolic were considered as having hypertension.
We excluded 64 subjects with missing albumin values, 163 missing other laboratory or anthropometric measures, 12 individuals with proteinuria, and 98 diabetic persons, leaving a total of 1799 subjects for the final analysis. For the analysis of measures of body composition, 50 persons had to be additionally excluded due to missing values or metallic implants, oedema or pregnancy etc.
We estimated age-adjusted mean levels of all correlates of interest by microalbuminuria status using analysis of covariance. Age-adjusted prevalences of categorical variables were estimated for men and women separately. Multiple logistic regression analyses were applied to assess the impact of multiple risk factors simultaneously on the prevalence odds of microalbuminuria. We considered firstorder interaction terms between the main risk factors of interest excluding those with a P-value Ͼ0.2. In the final model, only terms significant at the 0.05 level were retained. SAS system version 6.12 was used for the analyses.
Results
The overall, age-standardised prevalence of microalbuminuria among men was 8% and among women 7.5%. The prevalence increased substantially with age in both men and women ( Figure 1 ).
As shown in Table 1 , both men and women with microalbuminuria had a substantially worse profile concerning their ratio of body fat and composition (fat patterning). Microalbuminuric persons exhibited substantially higher average levels of waist circumference and waist-to-hip ratio, a higher prevalence of elevated waist circumference and central adiposity and obesity. Interestingly, women with microalbuminuria, but not men, had a significantly higher mean BMI and a higher average body fat content. Correspondingly, microalbuminuric women more frequently exhibited a higher prevalence of elevated body fat content or body fat percent (defined as greater or equal to the 80th gender-specific percentile).
Microalbuminuric men and women exhibited significantly higher levels of systolic and diastolic blood pressure and a higher frequency of hypertension than the respective normoalbuminuric groups Comparing men and women in Tables 1 and 2 with respect to the prevalence of established cardiovascular risk factors among microalbuminuria groups demonstrated very little gender differences in our study population. Thus, for subsequent analyses men and women were considered jointly and models adjusted for gender.
We stratified the population by hypertension status and calculated age and gender-adjusted prevalences ( Figure 2 ). While a marked stepwise increase in the prevalence of microalbuminuria was observed among non-hypertensives (n = 1356) across quintiles of waist-to-hip ratio, no relation was seen among hypertensives (n = 443).
Multivariate modelling of the prevalence odds of microalbuminuria (Table 3) consistently revealed central adiposity and hypertension to be the two most strongly associated correlates of microalbuminuria (in both men and women) while overall obesity and elevated waist circumference were not predictive. Model 1 shows the final model of the analysis of the independent predictors of microalbuminuria. Interactions between each anthropometric factor and hypertension were additionally considered. Interestingly, we found a highly significant interaction between central adiposity and hypertension (Model 2). The corresponding odds Figure 3 . Centrally adipose persons who were normotensive were 3.3 times more likely to be microalbuminuric. Hypertensives who were not centrally adipose were four times more likely to be microalbuminuric than normotensive, non-adipose individuals. Persons with both cen- Figure 3 Age-and gender-adjusted prevalence of microalbuminuria by hypertension status and high waist-to-hip ratio (WHR) and corresponding odds ratios and 95% confidence intervals (CI). MONICA Augsburg survey 1994/95, city of Augsburg. tral adiposity and hypertension had an odds ratio of microalbuminuria of 3.6. The interaction was also evident after calculation of the age and genderadjusted prevalences of microalbuminuria in those risk factor groups ( Figure 3 ). When these analyses were repeated incorporating information on body composition via an elevated percent body fat the results remained essentially unchanged even though a high percent body fat was in and of itself still highly associated with prevalent microalbuminuria.
Discussion
In our study population, we found consistent associations of microalbuminuria with measures of adiposity and body fat distribution in both men and women. The relation of microalbuminuria to waistto-hip was increasingly strong and positive particularly in the mid to upper part of the waist-to-hip distribution among non-hypertensives. Of the anthropometric measures and estimates of body composition and fatness available in this study, the waist-to-hip ratio was the measure most consistently and strongly associated with microalbuminuria.
The important role of central or abdominal vs peripheral fat distribution on urinary albumin excretion has been underscored by several studies. 4, 17, 18 In accordance with our results, Scaglione et al 4 report that both in normotensive and hypertensive (nondiabetic) individuals, only those with centrally located obesity but not those with peripheral obesity had elevated urinary albumin excretion rates. It is noteworthy that our study similar to Scaglione et al 4 found obesity (assessed via BMI) not to be associated with microalbuminuria once fat distribution (assessed via waist-to-hip ratio or via waist circumference) was taken into account. In a longitudinal study, Foyle et al 19 showed that non-diabetic persons with continued microalbuminuria had significantly higher waist-to-hip ratio and levels of fasting plasma insulin than persons without microalbuminuria. Thus a significant body of evidence has emerged that links microalbuminuria to one of the central components of the insulin resistance syndrome, ie central adiposity.
The relation of microalbuminuria with hypertension and severity of hypertension has long been established. Given these findings, we had expected to see also an association of central adiposity with microalbuminuria among hypertensives. In effect, we found a remarkable lack of such an association which was expressed by a significant statistical interaction (effect modification). Our findings can be interpreted in that both central adiposity and hypertension are each independently associated with increased odds of microalbuminuria. Their joint presence, at least in our study sample, did not raise the odds further. The exclusion of 98 diabetics from our analyses contributed but ultimately did not explain our findings in that upon inclusion of the diabetics, the parameter estimate of the interaction was reduced but still significant. As expected in the context of the metabolic syndrome, diabetics tended to exhibit more frequently hypertension, central adiposity and microalbuminuria. Another potential explanation may be selective response or survival if persons who are hypertensive and centrally adipose have a substantially higher mortality. Indirect evidence may be inferred from a longitudinal study Journal of Human Hypertension which reported a highly increased risk of coronary heart disease death among non-diabetic persons with hyperinsulinaemic microalbuminuria 21 given that the marked association between hyperinsulinaemia with both central adiposity and hypertension is well established. 22 Deckert et al 1 have proposed that microalbuminuria observed in non-diabetics may be the renal expression of general vascular endothelial damage. In this context, microalbuminuria is conceptualised as an early indicator of atherosclerosis. Yudkin et al 23 found microalbuminuria to be strongly and independently associated with coronary heart disease in a cross-sectional study of non-diabetics. More recently, it has been reported that persons with microalbuminuria had a greater intima-media thickness of the common carotid artery. 24 Our results are based exclusively on the urban population of the MONICA Augsburg study which presents a limitation of our study. The MONICA Augsburg study was specifically designed to generate representative estimates of risk factor levels within both the urban and the rural study area. It is well known that systematic differences between urban and rural populations exist. In our study, both male and female participants residing in Augsburg city tended to have higher systolic and diastolic blood pressure and cholesterol levels but lower BMI and waist-to-hip ratio levels than rural Augsburg participants. These differences clearly limit the generalisability of our findings.
In summary, evidence is accumulating that microalbuminuria should not merely be considered in the context of complications or consequences of clinical disorders such as diabetes or hypertension, but as a marker of endothelial damage and a potential component of the metabolic or insulin resistance syndrome. To further establish the temporal relation between the various components of the metabolic syndrome, longitudinal studies will be needed. Our cross-sectional results confirm the well known association between microalbuminuria and hypertension. More importantly, however, our population-based study confirms recent clinical findings regarding the strong relation of microalbuminuria with central adiposity, ie central or abdominal vs peripheral fat distribution, in a general urban adult population.
